Cargando…

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal soft tissue sarcoma of the gastrointestinal tract. Correct diagnosis with thorough use of pathologic and molecular tools of GIST mutations has been of the foremost importance. GIST are usually (95 %) KIT positive and harbor frequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poveda, Andrés, del Muro, Xavier García, López-Guerrero, Jose Antonio, Martínez, Virginia, Romero, Ignacio, Valverde, Claudia, Cubedo, Ricardo, Martín-Broto, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209233/ https://www.ncbi.nlm.nih.gov/pubmed/25193432 http://dx.doi.org/10.1007/s00280-014-2547-0

Ejemplares similares

2023 GEIS Guidelines for gastrointestinal stromal tumors
por: Serrano, César, et al.
Publicado: (2023)

Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
por: Garcia del Muro, Xavier, et al.
Publicado: (2015)

SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
por: Poveda, A., et al.
Publicado: (2016)

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
por: Serrano, César, et al.
Publicado: (2023)

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study
por: Maurel, Joan, et al.
Publicado: (2016)

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
por: Redondo, Andrés, et al.
Publicado: (2017)

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
por: Fernandez-Serra, Antonio, et al.
Publicado: (2020)

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
por: Martin-Broto, Javier, et al.
Publicado: (2023)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
por: Mora, J, et al.
Publicado: (2017)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
por: Pérez-Fidalgo, Jose Alejandro, et al.
Publicado: (2023)

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2023)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
por: Martínez-Trufero, Javier, et al.
Publicado: (2021)

A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST)
por: Judson, Ian, et al.
Publicado: (2002)

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
por: López-Pousa, A, et al.
Publicado: (2006)

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
por: López-Pousa, A., et al.
Publicado: (2016)

UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)
por: Judson, Ian, et al.
Publicado: (2017)

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2019)

Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers
por: Hoekstra, Harald J., et al.
Publicado: (2017)

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)
por: López-Pousa, A., et al.
Publicado: (2006)

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)
por: Poveda, A., et al.
Publicado: (2005)

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study
por: Giner, Francisco, et al.
Publicado: (2017)

The radiology of gastrointestinal stromal tumours (GIST)
por: Michael King, D
Publicado: (2005)

Capacity-building efforts by the AFHSC-GEIS program
por: Sanchez, Jose L, et al.
Publicado: (2011)

Antimicrobial resistance surveillance in the AFHSC-GEIS network
por: Meyer, William G, et al.
Publicado: (2011)

Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs
por: Mullen, Dorinda, et al.
Publicado: (2023)

Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007)

LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
por: LOUREIRO, Marcelo de Paula, et al.
Publicado: (2016)

Profile of patients with gastrointestinal stromal tumors (GIST)
por: PRACUCHO, Eduardo Marcucci, et al.
Publicado: (2015)

Imatinib treatment for gastrointestinal stromal tumour (GIST)
por: Lopes, Lisandro F, et al.
Publicado: (2010)

Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting
por: Frezza, Anna Maria, et al.
Publicado: (2017)

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients
por: Moura, David S., et al.
Publicado: (2018)

Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
por: Hauber, A Brett, et al.
Publicado: (2011)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
por: de Juan Ferré, A., et al.
Publicado: (2021)

Gastrointestinal stromal tumors (GISTs) of the stomach: a multicenter, retrospective study of curatively resected gastric GISTs
por: Kim, In-Hwan, et al.
Publicado: (2014)

Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates: Revolutions in treatment options in GIST
por: Farag, Sheima, et al.
Publicado: (2020)

2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
por: Frezza, Anna Maria, et al.
Publicado: (2018)

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
por: Jongsma, Hannah E., et al.
Publicado: (2017)

Segmental resection of the duodenum for gastrointestinal stromal tumor (GIST)
por: Mennigen, Rudolf, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j50quadqejrcnhbhf2blna34et